[Immediate Outcomes of Coronary Artery Bypass Grafting in Patients With Multifocal Atherosclerosis: Gender

A N Sumin1, E V Korok1, R A Gaifulin1

  • 1Research Institute for Complex Problems of Cardiovascular Diseases, Kemerovo, Russia.

Kardiologiia
|March 15, 2017
PubMed

Insights

Multifocal atherosclerosis (MFA) and gender do not impact perioperative complications after coronary artery bypass grafting (CABG). However, a history of CABG and specific coronary artery involvement increase risks for complications and mortality.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Cardiology

Background:

  • Ischemic heart disease (IHD) management often involves coronary artery bypass grafting (CABG).
  • Multifocal atherosclerosis (MFA) and patient demographics, including gender, may influence surgical outcomes.
  • Understanding these factors is crucial for optimizing patient care and risk stratification.

Purpose of the Study:

  • To evaluate the impact of multifocal atherosclerosis (MFA) and gender on immediate outcomes following coronary artery bypass grafting (CABG).
  • To identify specific patient characteristics and disease patterns associated with adverse events after CABG.

Main Methods:

  • Retrospective review of medical records for 764 patients undergoing elective CABG for IHD with MFA.
  • Analysis of demographic, clinical, and angiographic data.
  • Multivariate analysis to determine predictors of perioperative complications and in-hospital mortality.

Main Results:

  • Women presented with more comorbidities (e.g., diabetes, overweight, heart failure) and higher rates of carotid artery stenosis.
  • Men showed a higher prevalence of reduced left ventricular ejection fraction and peripheral artery disease.
  • No significant gender differences in overall perioperative complication rates were observed (48.8% in women vs. 53.0% in men).
  • History of prior CABG was linked to increased perioperative complications (p=0.034).
  • Combined involvement of the left main coronary artery (LMCA) and three coronary arteries significantly increased in-hospital mortality (p=0.003).

Conclusions:

  • Perioperative complication rates after CABG did not differ significantly between genders.
  • Women exhibited a distinct comorbidity profile and lesion distribution compared to men.
  • Independent risk factors for adverse outcomes include prior CABG, LMCA involvement, and three-vessel disease, irrespective of gender or MFA presence.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
497
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
486
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847